Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 41, Issue 8, 2014, Pages 1617-1623

  Graziosi, Maddalena ^a   Nanni, Cristina ^a   Lorenzini, Massimiliano ^a   Diemberger, Igor ^a   Bonfiglioli, Rachele ^a   Pasquale, Ferdinando ^a   Ziacchi, Matteo ^a   Biffi, Mauro ^a   Martignani, Cristian ^a   Bartoletti, Michele ^a   Tumietto, Fabio ^a   Boriani, Giuseppe ^a   Viale, Pier Luigi ^a   Fanti, Stefano ^a   Rapezzi, Claudio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Implantable cardioverter defibrillator; Infective endocarditis; Pacemaker; Positron emission tomography

Indexed keywords

ANTIBIOTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; CLINICAL ARTICLE; CLINICAL EVALUATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DEFIBRILLATOR; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOCARDIOGRAPHY; ENTEROCOCCUS; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HUMAN; LUNG EMBOLISM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; PROSPECTIVE STUDY; RADIODIAGNOSIS; SENSITIVITY AND SPECIFICITY; STREPTOCOCCUS GROUP D; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; ENDOCARDITIS, BACTERIAL; EVALUATION STUDY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MALE; MICROBIOLOGY; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING;

AGED; DEFIBRILLATORS, IMPLANTABLE; ENDOCARDITIS, BACTERIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84905563302     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-014-2773-z     Document Type: Article

References (34)

1. Baddour LM, Bettmann MA, Bolger AF, Epstein AE, Ferrieri P, Gerber MA, et al. Nonvalvular cardiovascular device-related infection. Circulation. 2003;108:2015-31.
2. Cabell CH, Heidenreich PA, Chu VH, Moore CM, Stryjewski ME, Corey GR, et al. Increasing rates of cardiac device infection among Medicare beneficiaries: 1990-1999. Am Heart J. 2004;147:582-6. (Pubitemid 38900441)
3. Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol. 2011;58:1001-6.
4. Baddour LM. Cardiac device infection - or not. Circulation. 2010;121:1686-7.
5. Li JS, Sexton DJ, Mick N, Nettles R, Fowler Jr VG, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633-8.
6. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al.; ESC Committee for Practice Guidelines (CPG). Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30:2369-413.
7. Habib G, Badano L, Tribouilloy C, Vilacosta I, Zamorano JL, Galderisi M, et al. Recommendations for the practice of echocardiography in infective endocarditis. Eur J Echocardiogr. 2010;11(2):202-19.
8. Evangelista A, Gonzalez-Alujas MT. Echocardiography in infective endocarditis. Heart. 2004;90:614-7. (Pubitemid 38668527)
9. Vilacosta I, Sarriai C, San Romran JA, Jimenez J, Castillo JA, Iturralde E, et al. Usefulness of transesophageal echocardiography for diagnosis of infected transvenous permanent pacemakers. Circulation. 1994;89:2684-7. (Pubitemid 24173688)
10. Lo R, D'Anca M, Cohen T, Kerwin T. Incidence and prognosis of pacemaker lead-associated masses: a study of 1,569 transesophageal echocardiograms. J Invasive Cardiol. 2006;18:599-601. (Pubitemid 46088085)
11. Victor F, De Place C, Camus C, Le Breton H, Leclercq C, Pavin D, et al. Pacemaker lead infection: echocardiographic features, management, and outcome. Heart. 1999;81:82-7. (Pubitemid 29113209)
12. Viganego F, O'Donoghue S, Eldadah Z, Shah MH, Rastogi M, Mazel JA, et al. Effect of early diagnosis and treatment with percutaneous lead extraction on survival in patients with cardiac device infection. Am J Cardiol. 2012;109:1466-71.
13. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc. 2008;83(1):46-53.
14. Kostakoglu L, Hardoff R, Mirtcheva R, Goldsmith S. PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake. Radiographics. 2004;24:1411-31. (Pubitemid 39329385)
15. Bertagna F, Bisleri G, Motta F, Merli G, Cossalter E, Lucchini S, et al. Possible role of F18-FDG-PET/CT in the diagnosis of endocarditis: preliminary evidence from a review of the literature. Int J Cardiovasc Imaging. 2012;28:1417-25.
16. Thuny F, Gaubert JY, Jacquier A, Tessonnier L, Cammilleri S, Raoult D, et al. Imaging investigation in infective endocarditis: current approach and prospectives. Arch Cardiovasc Dis. 2013;106:52-62.
17. Millar BC, Prandegrast BD, Alavi A, Moore JE. 18FDG-positron emission tomography (PET) has a role to play in the diagnosis and therapy of infective endocarditis and cardiac device infection. Int J Cardiol. 2013;167(5):1724-36.
18. Bonfiglioli R, Nanni C, Morigi JJ, Graziosi M, Trapani F, Bartoletti M, et al. 18F-FDG PET/CT diagnosis of ubexpected extracardiac septic embolismin patients with suspected cardiac endocarditis. Eur J Nucl Med Mol Imaging. 2013;40:1190-6.
19. Van Riet J, Hill EE, Gheysens O, Dymarkowski S, Herregods MC, Herijgers P, et al. 18F-FDG PET/CT for early detection of embolism and metastatic infection in patients with infective endocarditis. Eur J Nucl Med Mol Imaging. 2010;37:1189-97.
20. Ozcan C, Asmar A, Gill S, Thomassen A, Diederichsen ACP. The value of FDG-PET/CT in the diagnostic work-up of extra cardiac infectious manifestation in infectious endocarditis. Int J Cardiovasc Imaging. 2013;29:1629-37.
21. Sarrazin JF, Philippon F, Tessier M, Guimond J, Molin F, Champagne J, et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J Am Coll Cardiol. 2012;59:1616-25.
22. Bensimhon L, Lavergne T, Hugonne F, Mainardi JL, Latremouille C, Maunoury C, et al. Whole body 18Ffluorodeoxyglucose positron emission tomography imaging for the diagnosis of pacemaker or implantable cardioverter defibrillator infection: a preliminary prospective study. Clin Microbiol Infect. 2011;17:836-44.
23. Ploux S, Riviere A, Amraoui S, Whinnett Z, Barandon L, Lafitte S, et al. Positron emission tomography in patients with suspected pacing system infections may play a critical role in difficult cases. Heart Rhythm. 2011;8:1478-81.
24. Amraoui S, Texier-Maugein J, Bordachar P. PET scan in suspected but unproven pacemaker endocarditis. Arch Cardiovasc Dis. 2012;105:125-6.
25. Kumar R, Basu S, Torigian D, Anand V, Zhuang H, Alavi A. Role of modern imaging techniques for diagnosis of infection in the era of 18F- fluorodeoxyglucose positron emission tomography. Clin Microbiol Rev. 2008;21(1):209-24. (Pubitemid 351160016)
26. Balink H, Hut E, Pol T, Flokstra FJ, Roef M. Suppression of 18F-FDG myocardial uptake using a fat-allowed, carbohydrate-restricted diet. J Nucl Med Technol. 2011;39:185-9.
27. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007;49(18):1851-9. (Pubitemid 46661104)
28. Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010;121(3):458-77.
29. Wilkoff BL, Love CJ, Byrd CL, Bongiorni MG, Carrillo R, Crossely GH, et al. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm. 2009;6(7):1085-104.
30. Athan E, Chu V, Tattevin P, Selton-Suty C, Jones P, Naber C, et al. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA. 2012;307(16):1727-35.
31. Bongiorni MG, Tascini C, Tagliaferri E, Di Cori A, Soldati E, Leonildi A, et al. Microbiology of cardiac implantable electronic device infection. Europace. 2012;14:1334-9.
32. Kouijzer IJE, Vos FJ, Janssen JR, van Dijk APJ, Oyen WJG, Bleeker-Rovers CP. The value of 18F-FDG PET/CT in diagnosing infectious endocarditis. Eur J Nucl Med Mol Imaging. 2013;40(7):1102-7.
33. Treglia G, Bertagna F. Factors influencing the sensitivity of 18F-FDG PET/CT in the detection of infective endocarditis. Eur Nucl Med Mol Imaging. 2013;40:1112-3.
34. Kouijzer IJ, Vos FJ, Janssen MJ, van Dijk AP, Bleeker-Rovers CP, Oyen WJ. Reply to comment by Treglia and Bertagna: FDG PET/CT for detection of infectious endocarditis. Eur J Nucl Med Mol Imaging. 2013;40:1114-5.